71 related articles for article (PubMed ID: 1452563)
1. Study of foetal antigen in haematological malignancy.
Mukherjee N; Chatterjee D; Biswas TK; Sarkar M
J Assoc Physicians India; 1992 Jun; 40(6):384-7. PubMed ID: 1452563
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence and features of pre-B-cell acute lymphoblastic leukemia in Mexico: description of 9 patients].
Lobato-Mendizábal E; Ruiz-Argüelles GJ
Sangre (Barc); 1991 Feb; 36(1):1-5. PubMed ID: 1906639
[TBL] [Abstract][Full Text] [Related]
3. [Serum sialyl-Tn antigen in colorectal cancer and its relationship to prognosis].
Yamaguchi A; Tukioka Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1992 Mar; 19(3):349-53. PubMed ID: 1543361
[TBL] [Abstract][Full Text] [Related]
4. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
5. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
6. [Trials of the diagnostic potentials of TPA in tumorous and nontumorous lung pathologies in 303 cases].
Aquilina R; Bergero F; Magri G; Noceti P; Mirabelli S
Minerva Med; 1992; 83(7-8):415-9. PubMed ID: 1522964
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble Fas antigen in gastric MALT (mucosa-associated lymphoid tissue) lymphoma patients.
Doi T; Nishikawa Y; Endo H; Hosokawa Y; Tanimizu M; Hyodo I
J Exp Clin Cancer Res; 1999 Sep; 18(3):343-5. PubMed ID: 10606180
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
9. [Tumor markers in the diagnosis and prognosis of breast cancer].
Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
[TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase in neoplastic haematological diseases: confirmations, doubts and new findings.
Musto P; Longo S; Morelli A; Ficola U; Falcone A; Carotenuto M
Haematologica; 1988; 73(6):545-6. PubMed ID: 3148519
[No Abstract] [Full Text] [Related]
11. Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
Meier W; Stieber P; Hasholzner U; Baumgartner L; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2959-62. PubMed ID: 9329575
[TBL] [Abstract][Full Text] [Related]
12. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
13. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
Tam CS; Otero-Palacios J; Abruzzo LV; Jorgensen JL; Ferrajoli A; Wierda WG; Lerner S; O'Brien S; Keating MJ
Br J Haematol; 2008 Apr; 141(1):36-40. PubMed ID: 18324964
[TBL] [Abstract][Full Text] [Related]
15. [Fetal hemoglobin in children with different neoplasms].
Ibarra B; Montes J; Becerra C; Prea FJ; Barros-Núñez P; Aguilar-Luna JC; Arroyo J
Sangre (Barc); 1991 Oct; 36(5):383-6. PubMed ID: 1726190
[TBL] [Abstract][Full Text] [Related]
16. [Detection of low numbers of malignant cells in patients with leukemia or non-Hodgkin lymphoma: use of immunological markers].
van Dongen JJ; Hooijkaas H; Adriaansen HJ; Hählen K; van Zanen GE
Tijdschr Kindergeneeskd; 1986 Apr; 54(2):41-5. PubMed ID: 3520946
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
Babusíková O; Glasová M; Kusenda J; Koníková E; Mésárosová A
Neoplasma; 1994; 41(6):305-13. PubMed ID: 7870213
[TBL] [Abstract][Full Text] [Related]
18. Could beta-2-microglobulin be a useful diagnostic tool in malignant lymphoma and other haematological malignancy?
Krc I; Fischerová E
Acta Univ Palacki Olomuc Fac Med; 1985; 108():231-8. PubMed ID: 3161281
[No Abstract] [Full Text] [Related]
19. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
[TBL] [Abstract][Full Text] [Related]
20. Tumor M2-PK levels in haematological malignancies.
Oremek GM; Rox S; Mitrou P; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1135-8. PubMed ID: 12820361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
